Robert W. Postma - 29 Apr 2026 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 May 2026, 16:18:01 UTC
Prior SEC filing
15 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Postma, Robert W

Key filing fact

Robert W. Postma filed Form 4 for Alaunos Therapeutics, Inc. (TCRT) on 01 May 2026.

Key facts

  • This page summarizes Robert W. Postma's Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 01 May 2026, 16:18.

Change

  • Previous filing in this sequence was filed on 15 Jan 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001827847 Primary reporting owner

Postma Robert W

Relationship
Director
Address
C/O ALAUNOS THERAPEUTICS, INC., 501 E. LAS OLAS BLVD. SUITE 300, FORT LAUDERDALE
Signature
/s/ Postma, Robert W
Signature date
01 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TCRT transaction

Common Stock

Award

Transaction value
Shares
+6,274
Change %
+14%
Price
$2.59*
Shares after
50,146
Date
29 Apr 2026
Ownership
Direct
Footnotes
F1
TCRT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
24
Date
29 Apr 2026
Ownership
By spouse's IRA
TCRT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
62,416
Date
29 Apr 2026
Ownership
By WaterMill Asset Management Corp.
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares of common stock issued in lieu of board fees.

Footnote F2

The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .